These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18328249)

  • 1. Binding characterization of the interleukin-13 signaling complex and development of a ternary time-resolved fluorescence resonance energy transfer assay.
    Yang X; Lee J; Brooks J; Wilhelm J; Myszka D; Kasaian MT; Goldman S; Wolf S; Fitz LJ
    Anal Biochem; 2008 May; 376(2):206-12. PubMed ID: 18328249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A homogeneous time-resolved fluorescence resonance energy transfer assay for IL-13/IL-13Ralpha1 interaction.
    Yang X; Capotosto R; DiBlasio E; Hu Z; Kriz R; Lorenzo M; Malakian K; Wolfrom S; Wilhelm J; Wolf SF
    Anal Biochem; 2006 Apr; 351(1):158-60. PubMed ID: 16460661
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of action of interleukin-13 antagonist (IL-13E13K) in cells expressing various types of IL-4R.
    Kioi M; Kawakami K; Puri RK
    Cell Immunol; 2004 May; 229(1):41-51. PubMed ID: 15331327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
    Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
    Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
    Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
    Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
    Andrews AL; Holloway JW; Holgate ST; Davies DE
    J Immunol; 2006 Jun; 176(12):7456-61. PubMed ID: 16751391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the extracellular region of the human interleukin-4 receptor alpha chain and interleukin-13 receptor alpha1 chain by a silkworm-baculovirus system.
    Honjo E; Shoyama Y; Tamada T; Shigematsu H; Hatanaka T; Kanaji S; Arima K; Ito Y; Izuhara K; Kuroki R
    Protein Expr Purif; 2008 Jul; 60(1):25-30. PubMed ID: 18467124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of human IL-13 and implication for receptor binding.
    Moy FJ; Diblasio E; Wilhelm J; Powers R
    J Mol Biol; 2001 Jun; 310(1):219-30. PubMed ID: 11419948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of heterotrimeric G-protein and regulators of G-protein signaling interactions by time-resolved fluorescence resonance energy transfer.
    Leifert WR; Bailey K; Cooper TH; Aloia AL; Glatz RV; McMurchie EJ
    Anal Biochem; 2006 Aug; 355(2):201-12. PubMed ID: 16729956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human interleukin 4 receptor complex: neutralization effect of two monoclonal antibodies.
    Taremi SS; Prosise WW; Rajan N; O'Donnell RA; Le HV
    Biochemistry; 1996 Feb; 35(7):2322-31. PubMed ID: 8652573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equilibrium and kinetic analysis of human interleukin-13 and IL-13 receptor alpha-2 complex formation.
    Lacy ER
    J Mol Recognit; 2012 Mar; 25(3):184-91. PubMed ID: 22407982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
    Chen L; Liu Y; Hou Y; Kato Y; Sano H; Kanno T
    Neurosci Lett; 2007 Apr; 417(1):30-5. PubMed ID: 17398005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of interleukin-13-mediated cell activation by a novel inhibitory antibody to human IL-13 receptor alpha1.
    Krause S; Behrends J; Borowski A; Lohrmann J; Lang S; Myrtek D; Lorenzen T; Virchow JC; Luttmann W; Friedrich K
    Mol Immunol; 2006 Apr; 43(11):1799-807. PubMed ID: 16364441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of interleukin-13 activity by a recombinant human single-chain immunoglobulin domain directed against the IL-13 receptor alpha1 chain.
    Knackmuss S; Krause S; Engel K; Reusch U; Virchow JC; Mueller T; Kraich M; Little M; Luttmann W; Friedrich K
    Biol Chem; 2007 Mar; 388(3):325-30. PubMed ID: 17338640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of interleukin-13 and insights into receptor engagement.
    Eisenmesser EZ; Horita DA; Altieri AS; Byrd RA
    J Mol Biol; 2001 Jun; 310(1):231-41. PubMed ID: 11419949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of a functional IL-13Ralpha1 by rat B cells.
    Pierrot C; Beniguel L; Bègue A; Khalife J
    Biochem Biophys Res Commun; 2001 Oct; 287(4):969-76. PubMed ID: 11573960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potent antagonist antibodies against mouse IL-13Rα1 using novel bioassays.
    Edwards KM; Huynh H; Prasad R; McDonald A; Hardy MP; Scotney P; Owczarek CM; Busfield SJ; Panousis C; Wilson NJ
    J Immunol Methods; 2014 May; 407():48-57. PubMed ID: 24704819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors.
    Zhou V; Han S; Brinker A; Klock H; Caldwell J; Gu XJ
    Anal Biochem; 2004 Aug; 331(2):349-57. PubMed ID: 15265741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4.
    Sharif O; Hu H; Klock H; Hampton EN; Nigoghossian E; Knuth MW; Matzen J; Anderson P; Trager R; Uno T; Glynne RJ; Azarian SM; Caldwell JS; Brinker A
    Anal Biochem; 2009 Sep; 392(2):162-8. PubMed ID: 19482004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional effect of the R110Q IL13 genetic variant alone and in combination with IL4RA genetic variants.
    Chen W; Ericksen MB; Levin LS; Khurana Hershey GK
    J Allergy Clin Immunol; 2004 Sep; 114(3):553-60. PubMed ID: 15356556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.